FrancophonIA/ELRC3.0 huggingface dataset:
English: Enrofloxacin is a synthetic chemotherapeutic agent from the class of the fluoroquinolone carboxylicacid derivatives.
Maltese: Enrofloxacin huwa aġent kemoterapewtiku sintetiku mill-klassi tad-derivattivi talfluoroquinolone carboxylic-acid.
English: La Selva, 135 17170 Amer Girona
Maltese: 17170 Amer
English: Staphylococcus spp., Escherichia coli, Pasteurella spp., Klebsiella spp., Bordetella spp., Pseudomonas spp., Proteus spp.
Maltese: Staphylococcus spp., Escherichia coli, Pasteurella spp., Klebsiella spp., Bordetella spp., Pseudomonas spp.
English: 2065m 06516 Carros Cedex France
Maltese: 1ére Avenue L.I.D. 2065m 06516 Carros Cedex Franza
English: 08028 Barcelona Spain
Maltese: 08028 Barcelona Spanja
English: Cattle (subcutaneous)
Maltese: Ħnieżer (qżieqeż)
English: Bielawa Poland
Maltese: Bielawa Il-Polonja
English: The efficacy against M. haemolytica and Mycoplasma bovis has been justified with several experimental studies in which induced infection with M. haemolytica and M. bovis was produced.
Maltese: L-effikaċja kontra M. haemolytica u Mycoplasma bovis ġiet iġġustifikata permezz ta' bosta studji sperimentali li fihom ġiet prodotta infezzjoni indotta bi M. haemolytica u M. bovis.
English: Biowet Puławy Sp. z o.o.
Maltese: Il-Polonja Biowet Puławy Sp. z o.o. 2 Arciucha Str.
English: Slovenia aniMedica GmbH Im Südfeld 9
Maltese: Is-Slovenja aniMedica GmbH Im Südfeld 9
English: The PK/PD analysis shows that the PK/PD ratios are largely exceeded for Gram-negative pathogens.
Maltese: Lanaliżi PK/PD turi li l-proporzjonijiet PK/PD jinqabżu eċċessivament għall-patoġeni Gram-negattivi.
English: Via Emilia, 285 Ozzano Emilia (BO) Italy
Maltese: Ozzano Emilia (BO) L-Italja
English: PFO "Vetos-Farma" Sp. z o.o.
Maltese: Il-Polonja PFO "Vetos-Farma" Sp. z o.o. 21 Dzierżoniowska Str.
English: Bayer Animal Health GmbH Kaiser-Wilhelm-Allee 50 51368 Leverkusen Germany
Maltese: Bayer Animal Health GmbH Kaiser-Wilhelm-Allee 50 51368 Leverkusen
English: Laboratorios Syva S.A. Parroco Pablo Diez, 49-57 24010 Leon
Maltese: Laboratorios Syva S.A. Parroco Pablo Diez, 49-57 24010
English: Animalcare Ltd 10 Great North Way York Business Park Nether Poppleton York
Maltese: Animalcare Group plc. 10 Great North Way York Business Park Nether Poppleton York
English: Low to moderate (8% to 20%) resistance rates to ciprofloxacin have been observed in indicator isolates of E. coli for the different target species in different European countries.
Maltese: Rati ta' reżistenza baxxi sa moderati (8% sa 20%) għal ciprofloxacin ġew osservati fl-iżolati indikaturi ta' E. coli għall-ispeċijiet fil-mira differenti f'pajjiżi Ewropej differenti.
English: Hifarmax, Produtos e serviços veterinários, Lda Av. Marechal Craveiro Lopes nº96 R/C
Maltese: Marechal Craveiro Lopes nº96 R/C
English: Lublin Poland
Maltese: Lublin Il-Polonja
English: 3 http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/veterinary/referrals/Hipralona_Enro
Maltese: 3 http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/veterinary/referrals/Hipralona_EnroS/vet_referral_000067.jsp&mid=WC0b01ac05805c5170
English: The clinical parameters improved.
Maltese: Il-parametri kliniċi tjiebu.
English: IV: Meat and offal: 5 days.
Maltese: IV: Laħam u l-ġewwieni: 5 ijiem.
English: For some serious animal indications, fluoroquinolones could be the only alternative available (EMEA/CVMP/SAGAM/184651/2005)7.
Maltese: Għal xi indikazzjonijiet tal-annimali serji, il-fluoroquinolones jistgħu jkunu l-unika alternattiva disponibbli (EMEA/CVMP/SAGAM/184651/2005)7.
English: Baytril 2.5% injectable, Baytril 5% injectable, Baytril 10% injectable and associated names, and related veterinary medicinal products authorised under Article 13 of Directive 2001/82/EC, as amended are solutions for injection containing enrofloxacin at 25 mg/ml, 50 mg/ml and 100 mg/ml respectively.
Maltese: Baytril 2.5% injettabbli, Baytril 5% injettabbli, Baytril 10% injettabbli u ismijiet assoċjati, u l-prodotti mediċinali veterinarji relatati awtorizzati skont l-Artikolu 13 tad-Direttiva 2001/82/KE, kif emendata huma soluzzjonijiet għall-injezzjoni li fihom enrofloxacin bi 25 mg/ml, 50 mg/ml u 100 mg/ml rispettivament.
English: Germany Albrecht GmbH Hauptstr.
Maltese: Il-Ġermanja Albrecht GmbH Hauptstr. 6-8
English: Milk: 3 days.
Maltese: Ħalib: 3 ijiem.
English: Laboratorios Syva S.A. Parroco Pablo Diez, 49 - 57 24010 Leon
Maltese: Il-Bulgarija Laboratorios Syva S.A. Parroco Pablo Diez, 49 - 57 24010
English: Laboratorios Hipra S.A. Avda.
Maltese: Is-Slovakkja Laboratorios Hipra S.A. Avda.
English: Similarly, for Mycoplasma spp.
Maltese: Pasteurella multocida, Mycoplasma spp.
English: ad us. vet.
Maltese: Nagħaġ:
English: 105b D-06406 Bernburg
Maltese: Il-Ġermanja Serumwerk Bernburg AG Hallesche Landstr. 105b D-06406 Bernburg
English: Lithuania Vetoquinol Biowet Sp z o.o.
Maltese: Il-Litwanja Vetoquinol Biowet Sp z o.o. 13/14
English: Acute severe mastitis caused by Escherichia coli (100 mg/ml strength)
Maltese: Mastite gravi akuta kkawżata minn Escherichia coli (qawwa ta' 100 mg/ml)
English: Three different doses of enrofloxacin were administered: 1.25, 2.5 or 5 mg/kg bw/day for 3 days.
Maltese: Ingħataw tliet dożi differenti ta' enrofloxacin: 1.25, 2.5 jew 5 mg/kg bw/jum għal 3 ijiem.
English: Milk: 4 days.
Maltese: Ħalib: 4 ijiem.
English: aureus) was 39.5% in the 2.5 mg/kg group and 82% in the 5 mg/kg group.
Maltese: Il-perċentwal ta' kura batterjoloġika (Staph. aureus) kien 39.5% fil-grupp ta' 2.5 mg/kg u 82% fil-grupp ta' 5 mg/kg.
English: These data are supported by published literature.
Maltese: Din id-dejta hija appoġġata minn letteratura ppubblikata.
English: Puławy Poland
Maltese: Puławy Il-Polonja
English: Calves:
Maltese: Klieb:
English: The efficacy at the dosage of 2.5 mg/kg bw daily for 3 days was compared to the one of a trimetroprim-sulfamid fixed combination (30 mg/kg bw daily for 3 days).
Maltese: L-effikaċja fid-dożaġġ ta' 2.5 mg/kg bw darba kuljum għal 3 ijiem tqabblet ma' dik ta' kombinazzjoni fissa ta' trimetroprimsulfamid (30 mg/kg bw darba kuljum għal 3 ijiem).
English: Pharmagal, s.r.o.
Maltese: Is-Slovakkja Pharmagal, s.r.o.
English: The overall recovery rate was 46.7%.
Maltese: Ir-rata ta' rkupru globali kienet 46.7%.
English: Mommaertslaan 14 1831 Diegem
Maltese: Bayer SA-NV J.E. Mommaertslaan 14 1831 Diegem Machelen
English: (e.g. Pasteurella multocida), Bordetella spp., Proteus spp., Pseudomonas spp., against Gram-positive bacteria such as Staphylococcus spp.
Maltese: (eż. Pasteurella multocida), Bordetella spp., Proteus spp., Pseudomonas spp., kontra batterji pożittivi għal Gram bħal Staphylococcus spp.
English: An untreated group was included.
Maltese: Ġie inkluż grupp mhux ikkurat.
English: Filiala Filipesti SRL Str. Principala nr. 944 Filipestii de Padure Jud.
Maltese: Filipestii de Padure Jud.
English: Resistance to fluoroquinolones has been reported to arise from five sources, (i) point mutations in the genes encoding for DNA gyrase and/or topoisomerase IV leading to alterations of the respective enzyme, (ii) alterations of drug permeability in Gram-negative bacteria, (iii) efflux mechanisms, (iv) plasmid mediated resistance and (v) gyrase protecting proteins.
Maltese: Ir-reżistenza għall-fluoroquinoles ġiet irrapportata li tirriżulta minn ħames sorsi, (i) mutazzjonijiet talpunt fil-ġeni li jikkodifikaw għall-gyrase tad-DNA u/jew għat-topoisomerase IV li jwasslu għal bidliet flenzima rispettiva, (ii) bidliet fil-permeabilità tal-mediċina f'batterji Gram-negattivi, (iii) mekkaniżmi ta' effluss, (iv) reżistenza medjata mill-plasmid u (v) proteini li jipproteġu l-gyrase.
English: Cross-resistance within the fluoroquinolone class of antimicrobials is common.
Maltese: Ir-reżistenza trasversali fi ħdan il-klassi fluoroquinolone ta' antimikrobiċi hija komuni.
English: The critical PK parameters in milk were determined following intravenous administration of the 100 mg/ml strength and used to calculate the predictive PK/PD ratios together with MIC90 values for E. coli.
Maltese: Il-parametri PK kritiċi fil-ħalib ġew determinati wara l-amministrazzjoni intravenali tal-qawwa ta' 100 mg/ml u ġew użati għall-kalkolu talproporzjonijiet PK/PD ta' previżjoni flimkien mal-valuri MIC90 għal E. coli.
English: Taking into account all data available (clinical, PK/PD and antimicrobial resistance data), the CVMP considered that this indication can be accepted.
Maltese: Filwaqt li qies id-dejta kollha disponibbli (dejta klinika, PK/PD u dwar ir-reżistenza antimikrobika), isCVMP qies li din l-indikazzjoni tista' tiġi aċċettata.
English: 9 CVMP guideline on safety and residue data requirements for veterinary medicinal products intended for minor uses or minor species (EMEA/CVMP/SWP/66781/2005)http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004581.pdf span of 20% to compensate for deficiencies in the study results in a withdrawal period of 6 days recommended for rabbit meat and offal for animals treated at the recommended dose of 10 mg/kg bw with the 25 mg/ml strength by subcutaneous injection.
Maltese: 9 CVMP guideline on safety and residue data requirements for veterinary medicinal products intended for minor uses or minor species (EMEA/CVMP/SWP/66781/2005)http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004581.pdf tiżmim irrakkomandat ta' 4 ijiem għall-ħalib tal-annimali tal-ifrat jista' jiġi estrapolat direttament għallħalib tal-mogħoż meta l-annimali jkunu kkurati bid-doża rrakkomandata ta' 5 mg/kg bw bil-qawwa ta' 50 mg/ml u 100 mg/ml b'injezzjoni taħt il-ġilda.
English: Vetoquinol Biowet Sp z o.o.
Maltese: L-Estonja Vetoquinol Biowet Sp z o.o. 13/14
English: The results from the pharmacokinetic/pharmacodynamic (PK/PD) analysis with M. haemolytica were not fully predictive of clinical efficacy.
Maltese: Ir-riżultati millanaliżi farmakokinetika/farmakodinamika (PK/PD) bi M. haemolytica ma kinux predikattivi bis-sħiħ taleffikaċja klinika.
English: Treatment of post-partum dysgalactiae syndrome (PDS), mastitis, metritis, agalactia (MMA syndrome) caused by enrofloxacin susceptible strains of Escherichia coli, Klebsiella spp.
Maltese: Il-kura tas-sindrome dysgalactiae post-partum (PDS), mastite, metrite, agalaktja (sindrome MMA) kkawżati minn razez ta' Escherichia coli, Klebsiella spp. li huma suxxettibbli għal enrofloxacin.
English: Meat and offal: 5 days.
Maltese: Laħam u l-ġewwieni: 5 ijiem.
English: CENAVISA SA LABORATORIOS Cami Pedra Estela s/n 43205 REUS
Maltese: Ir-Rumanija CENAVISA SA LABORATORIOS Cami Pedra Estela s/n
English: All available clinical data referred to pet rabbits only.
Maltese: Id-dejta klinika kollha disponibbli kienet tirreferi għall-fniek domestiċi biss.
English: Meat and offal: 6 days.
Maltese: Laħam u l-ġewwieni: 6 ijiem.
English: Enrofloxacin is active against many Gram-negative bacteria such as Escherichia coli, Klebsiella spp., Actinobacillus pleuropneumoniae, Mannheimia haemolytica, Pasteurella spp.
Maltese: Enrofloxacin huwa attiv kontra diversi batterji negattivi għal Gram bħal Escherichia coli, Klebsiella spp., Actinobacillus pleuropneumoniae, Mannheimia haemolytica, Pasteurella spp.
English: Two enzymes essential in DNA replication and transcription, DNA gyrase and topoisomerase IV, have been identified as the molecular targets of fluoroquinolones.
Maltese: Żewġ enzimi essenzjali fir-replikazzjoni u t-traskrizzjoni tad-DNA, id-DNA gyrase u t-topoisomerase IV, ġew identifikati bħala l-miri molekulari ta' fluoroquinolones.
English: Two different enrofloxacin treatment schemes were investigated: 5 mg/kg bw for 3 days and 2.5 mg/kg for 5 days.
Maltese: Ġew investigati żewġ skemi ta' kura differenti b'enrofloxacin: 5 mg/kg bw għal 3 ijiem u 2.5 mg/kg għal 5 ijiem.
English: Treatment of post-partum dysgalactiae syndrome, PDS (MMA syndrome) caused by enrofloxacin susceptible strains of Escherichia coli and Klebsiella spp.
Maltese: Kura tas-sindromu post-partum dysgalactiae, PDS (sindromu MMA) ikkawżata minn razez suxxettibbli għal enrofloxacin ta' Escherichia coli u Klebsiella spp.
English: - Dosage: 5 mg/kg bw, once daily for 5 days
Maltese: - Dożaġġ: 5 mg/kg bw, darba kuljum għal 5 ijiem
English: Injectable enrofloxacin decreased diarrhoea incidence up to 70% in suckling piglets.
Maltese: Enrofloxacin injettabbli naqqas l-inċidenza tad-dijarea sa 70% fil-qżieqeż mhux miftuma.
English: Rodents
Maltese: Rodituri
English: Add, to all products and delete the existing text: 5.1 Pharmacodynamic properties
Maltese: Żid, mal-prodotti kollha u ħassar it-test eżistenti: 5.1 Kwalitajiet farmakodinamiċi
English: To compensate for deficiencies in the studies a safety span of 20% was considered appropriate, resulting in a withdrawal period of 96 hours (4 days).
Maltese: Sabiex jiġu kkumpensati n-nuqqasijiet fl-istudji tqieset xierqa firxa ta' sikurezza ta' 20%, u dan irriżulta f'perjodu ta' tiżmim ta' 96 siegħa (4 ijiem).
English: Therefore PK/PD and resistance data were taken into account when considering the efficacy of enrofloxacin against Pasteurella multocida.
Maltese: Għalhekk tqieset id-dejta PK/PD u dwar ir-reżistenza meta ġiet ikkunsidrata l-effikaċja ta' enrofloxacin kontra Pasteurella multocida.
English: Enrofloxacin is active against many Gram-negative bacteria such as Escherichia coli, Klebsiella spp., Actinobacillus pleuropneumoniae, Pasteurella spp.
Maltese: Enrofloxacin huwa attiv kontra diversi batterji negattivi għal Gram bħal Escherichia coli, Klebsiella spp., Actinobacillus pleuropneumoniae, Pasteurella spp.
English: Reptiles
Maltese: Rettili
English: The withdrawal period was statistically calculated by means of the TTSC method (i.e. where residues in all animals fall below the level considered safe within the time span for which data are available) resulting in 5.6 milkings / 3 days.
Maltese: Il-perjodu ta' tiżmim ġie kkalkolat b'mod statistiku permezz tal-metodu TTSC (jiġifieri fejn ir-residwi fl-annimali kollha jaqgħu taħt il-livell meqjus sigur fil-firxa ta' żmien li għalih hemm dejta disponibbli) u dan irriżulta f'5.6 darbiet ta' ħlib / 3 ijiem.
English: An extension of the treatment interval to 48 hours may be necessary in individual cases.
Maltese: Jaf tkun meħtieġa estensjoni tal-intervall ta' kura sa 48 siegħa f'każijiet individwali.
English: (e.g. Staphylococcus aureus) and against Mycoplasma spp.
Maltese: Staphylococcus aureus) u kontra Mycoplasma spp. fid-dożi terapewtiċi rakkomandati.
English: Lithuania FORTE Healthcare Limited Cougar Lane
Maltese: Il-Polonja FORTE Healthcare Limited Cougar Lane
English: On 22 April 2013, Spain presented to the European Medicines Agency (the Agency) a referral notification under Article 35 of Directive 2001/82/EC for Baytril 2.5% injectable, Baytril 5% injectable, Baytril 10% injectable and associated names, and related veterinary medicinal products authorised under Article 13 of Directive 2001/82/EC, as amended.
Maltese: Fit-22 ta' April 2013, Spanja ppreżentat notifika ta' riferiment lill-Aġenzija Ewropea għall-Mediċini (lAġenzija) skont l-Artikolu 35 tad-Direttiva 2001/82/KE għal Baytril 2.5% injettabbli, Baytril 5% injettabbli, Baytril 10% injettabbli u ismijiet assoċjati, u l-prodotti mediċinali veterinarji relatati awtorizzati skont l-Artikolu 13 tad-Direttiva 2001/82/KE, kif emendata.
English: Meat and offal: 4 days.
Maltese: Laħam u l-ġewwieni: 4 ijiem.
English: Germany Krka d.d.
Maltese: L-Irlanda Krka d.d. Novo mesto
English: Сиваквинол - 100 Инжекционен разтвор
Maltese: Сиваквинол - 100
English: Therefore PK/PD and resistance data were taken into account when considering the efficacy of enrofloxacin against Mycoplasma spp.
Maltese: Għalhekk tqieset id-dejta PK/PD u dwar ir-reżistenza meta ġiet ikkunsidrata l-effikaċja ta' enrofloxacin kontra Mycoplasma spp.
English: Arthritis caused by Mycoplasma bovis (50 mg/ml and 100 mg/ml strengths)
Maltese: L-artrite kkawżata minn Mycoplasma bovis (qawwiet ta' 50 mg/ml u 100 mg/ml)
English: Clinical and bacteriological cure were obtained.
Maltese: Inkisbu kura klinika u kura batterjoloġika.
English: Better clinical results were observed in 3-4 weeks old animals compared to 1-2 weeks old animals.
Maltese: Ġew osservati riżultati kliniċi aħjar fl-annimali li għandhom bejn 3-4 ġimgħat meta mqabbla mal-annimali li għandhom bejn ġimgħa 1 u ġimagħtejn 2.
English: 20 mg/kg bw, corresponding to 0.8 ml/kg bw, once daily by intramuscular injection for 5 to 10 consecutive days.
Maltese: 20 mg/kg bw, li tikkorrispondi għal 0.8 ml/kg bw, darba kuljum b'injezzjoni ġol-muskolu għal 5 sa 10 ijiem konsekuttivi.
English: Overall summary of the scientific evaluation of Baytril 2.5% injectable, Baytril 5% injectable, Baytril 10% injectable and associated names, and related veterinary medicinal products authorised under Article 13 of Directive 2001/82/EC, as amended (see Annex I)
Maltese: Sommarju globali tal-evalwazzjoni xjentifika ta' Baytril 2.5% injettabbli, Baytril 5% injettabbli, Baytril 10% injettabbli u ismijiet assoċjati, u l-prodotti mediċinali veterinarji relatati awtorizzati skont l-Artikolu 13 tad-Direttiva 2001/82/KE, kif emendata (ara Anness I)
English: Treatment of infections of the alimentary and respiratory tracts caused by enrofloxacin susceptible strains of: Escherichia coli, Pasteurella multocida and Staphylococcus spp.
Maltese: Kura ta' infezzjonijiet fil-passaġġi alimentari u respiratorji kkawżati minn razez suxxettibbli għal enrofloxacin ta': Escherichia coli, Pasteurella multocida u Staphylococcus spp.
English: GENERA Slovenia d.o.o.
Maltese: Is-Slovenja GENERA Is-Slovenja d.o.o. Dunajska 51
English: 5-10 mg/kg bw, corresponding to 0.2-0.4 ml/kg bw, once daily by intramuscular injection for 5 consecutive days.
Maltese: 5-10 mg/kg bw, li tikkorrispondi għal 0.2-0.4 ml/kg bw, darba kuljum b'injezzjoni ġol-muskolu għal 5 ijiem konsekuttivi.
English: - Dosage: 5 mg/kg bw, once daily for 3 days by intramuscular injection.
Maltese: - Dożaġġ: 5 mg/kg bw, darba kuljum għal 3 ijiem permezz ta' injezzjoni ġol-muskolu.
English: Vetpharma Animal Health, S.L.
Maltese: Vetpharma Animal Health, S.L. Les Corts 23.
English: Germany Industrial Veterinaria SA C/Esmeralda 19-21
Maltese: L-Irlanda Industrial Veterinaria SA C/Esmeralda 19-21
English: A harmonised withdrawal period of 5 days can be accepted for cattle meat and offal when animals are treated at the recommended dose of 5 mg/kg bw with either the 50 mg/ml strength or the 100 mg/ml strengths administered intravenously.
Maltese: Perjodu ta' tiżmim armonizzat ta' 5 ijiem jista' jiġi aċċettat għal-laħam u l-ġewwieni tal-ifrat meta l-annimali jkunu kkurati bid-doża rrakkomandata ta' 5 mg/kg bw bil-qawwa ta' 50 mg/ml jew 100 mg/ml mogħtija ġol-vina.
English: Belgium Industrial Veterinaria SA C/Esmeralda 19-21
Maltese: Il-Belġju Industrial Veterinaria SA C/Esmeralda 19-21
English: Acute mastitis caused by Escherichia coli: 5 mg enrofloxacin/kg bw, corresponding to 1 ml/20 kg bw, by slow intravenous injection once daily for two consecutive days.
Maltese: Mastite akuta kkawżata minn Escherichia coli: 5 mg enrofloxacin/kg bw, li tikkorrispondi għal 1 ml/20 kg bw, b'injezzjoni bil-mod ġol-vina darba kuljum għal jumejn konsekuttivi.
English: Target species, indications and posology
Maltese: Speċi fil-mira, indikazzjonijiet u pożoloġija
English: Reptiles are ectothermic, relying on external heat sources to maintain their body temperature at the optimum level for correct function of all body systems.
Maltese: Ir-rettili huma ektotermiċi, peress li jiddependu fuq sorsi ta' sħana esterni biex iżommu t-temperatura tal-ġisem tagħhom fil-livell ottimali għall-funzjoni korretta tas-sistemi kollha tal-ġisem.
English: Warning sentences have been included in sections 4.5 and 4.6 of the SPC regarding the potential articular cartilage damage in growing cattle and lambs, based on the available literature.
Maltese: Ġew inklużi frażijiet ta' twissija fis-sezzjonijiet 4.5 u 4.6 tal-SPC fir-rigward tal-ħsara potenzjali filqarquċa artikulari fl-annimali tal-ifrat u l-ħrief, abbażi tal-letteratura disponibbli.
English: Finally, resistance to ciprofloxacin in Enterococcus bacteria varied from 0 to 29% in cattle and from 0 to 33% in pigs.
Maltese: Fl-aħħar nett, ir-reżistenza għal ciprofloxacin fil-batterji ta' Enterococcus varjat minn 0% sa 29% flannimali tal-ifrat u minn 0% sa 33% fil-ħnieżer.
English: The 2012 RESAPATH annual report indicated that more than 90% of Pasteurella in goats are sensitive to enrofloxacin.
Maltese: Ir-rapport annwali tal-2012 tal-RESAPATH indika li iktar minn 90% ta' Pasteurella fil-mogħoż huma sensittivi għal enrofloxacin.
English: Goats:
Maltese: Qtates:
English: Germany Laboratorios Calier, S.A. c/ Barcelonès, 26 (Pla del Ramassà)
Maltese: Il-Polonja Laboratorios Calier, S.A. c/ Barcelonès, 26 (Pla del Ramassà)
English: aureus and E. coli were identified.
Maltese: Fil-kampjuni tal-ħalib ġew identifikati l-patoġeni Staph. aureus u E. coli.
English: Pigs, rabbits, dogs, cats, exotic animals (mammals, birds, reptiles)
Maltese: Majjali, fniek, klieb, qtates, annimali eżotiċi (mammali, għasafar, rettili)
English: A positive control group treated with oxytetracyclin and an untreated group were included.
Maltese: Ġew inklużi grupp ta' kontroll pożittiv ikkurat b'oxytetracyclin u grupp mhux ikkurat.
English: Antibacterial spectrum
Maltese: Firxa antibatterika
English: Cattle, pigs, sheep, goats
Maltese: Klieb, frat, tjur, qtates, majjali
English: A dose-confirmation study and a field study showed clinical efficacy of the dose of 5 mg/kg bw/day against enzootic pneumonia caused by M. haemolytica and P. multocida.
Maltese: Studju ta' konferma tad-doża u studju fuq il-post urew effikaċja klinika tad-doża ta' 5 mg/kg bw/jum kontra l-pulmonite enżootika kkawżata minn M. haemolytica u P. multocida.
English: 3641 RT Mijdrecht Netherlands
Maltese: 3641 RT Mijdrecht Il-Pajjiżi l-Baxxi
English: PK/PD and antimicrobial resistance data have been taken into account to justify this indication.
Maltese: Id-dejta PK/PD u dwar ir-reżistenza antimikrobika tqieset biex tiġi ġġustifikata din l-indikazzjoni.
English: Treatment of infections of the alimentary tract and septicaemia caused by enrofloxacin susceptible strains of Escherichia coli (50 mg/ml and 100 mg/ml strengths)
Maltese: Il-kura ta' infezzjonijiet tal-passaġġ alimentari u s-settiċemija kkawżati minn razez ta' Escherichia coli suxxettibbli għal enrofloxacin (qawwiet ta' 50 mg/ml u 100 mg/ml)
English: Milk (50 mg/ml and 100 mg/ml strengths): One residue depletion studies was provided with animals treated at 5 mg/kg bw for 5 days.
Maltese: Ħalib (qawwiet ta' 50 mg/ml u 100 mg/ml): Ġie pprovdut studju wieħed dwar it-tnaqqis tar-residwi blannimali kkurati b'doża ta' 5 mg/kg bw għal 5 ijiem.
English: Calves
Maltese: Prahova
English: The indications assessed are considered to be aligned with the principles of responsible use of fluoroquinolones in animals.
Maltese: L-indikazzjonijiet ivvalutati huma meqjusa li huma allinjati mal-prinċipji tal-użu responsabbli talfluoroquinolones fl-annimali.
English: Moderate to high resistance rates to ciprofloxacin were found for Campylobacter spp.
Maltese: Instabu rati ta' reżistenza moderati sa għoljin għal ciprofloxacin għal Campylobacter spp.
English: Belgium Laboratorios Calier, S.A. c/ Barcelonès, 26 (Pla del Ramassà)
Maltese: Il-Belġju Laboratorios Calier, S.A. c/ Barcelonès, 26 (Pla del Ramassà)
English: An enrofloxacin intramuscular injection at 2.5 mg/kg bw, administered once daily until the clinical signs of respiratory disease decreased, resulted in a 94.5% success rate.
Maltese: Injezzjoni ġol-muskolu ta' enrofloxacin ta' 2.5 mg/kg bw, mogħtija darba kuljum sakemm is-sinjali kliniċi tal-marda respiratorja naqsu, irriżultat f'rata ta' suċċess ta' 94.5%.
English: Data show low resistance rates to enrofloxacin/ciprofloxacin in Salmonella spp.
Maltese: Id-dejta turi rati ta' reżistenza baxxi għal enrofloxacin/ciprofloxacin fl-iżolati ta' Salmonella mill-annimali tal-ifrat u l-ħnieżer.
English: Belgium Vetpharma Animal Health, S.L.
Maltese: Il-Belġju Vetpharma Animal Health, S.L. Les Corts 23.
English: ENROCARE 50 MG/ML INJECTABLE POUR BOVINS PORCINS CHIENS ET CHATS
Maltese: MG/ML INJECTABLE POUR BOVINS PORCINS CHIENS ET CHATS